Your browser doesn't support javascript.
loading
Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
Sanders, Gillian D; Bayoumi, Ahmed M; Sundaram, Vandana; Bilir, S Pinar; Neukermans, Christopher P; Rydzak, Chara E; Douglass, Lena R; Lazzeroni, Laura C; Holodniy, Mark; Owens, Douglas K.
Affiliation
  • Sanders GD; Duke Clinical Research Institute, Duke University, Durham, NC 27715, USA. gillian.sanders@duke.edu
N Engl J Med ; 352(6): 570-85, 2005 Feb 10.
Article in En | MEDLINE | ID: mdl-15703422
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Mass Screening / Decision Support Techniques Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male Language: En Journal: N Engl J Med Year: 2005 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Mass Screening / Decision Support Techniques Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male Language: En Journal: N Engl J Med Year: 2005 Document type: Article Affiliation country: Country of publication: